Curran Simpson, SVP, Product Development & CTO at REGENXBIO Inc. (RGNX), sold 43,832 shares at $50.08 ($2.2M) on 2019-02-05, disclosed to the SEC on 2019-02-07.
Open-market sale of $2.2M RGNX by SVP, Product Development & CTO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |